Huichun Zhan

1.1k total citations
40 papers, 682 citations indexed

About

Huichun Zhan is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Huichun Zhan has authored 40 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 24 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in Huichun Zhan's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Huichun Zhan is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Huichun Zhan collaborates with scholars based in United States and China. Huichun Zhan's co-authors include Kenneth Kaushansky, Jerry L. Spivak, Chi Hua Sarah Lin, Chi V. Dang, Alison R. Moliterno, Yoon-Young Jang, Prashant Mali, Sarah N. Dowey, Donna M. Williams and Zhaohui Ye and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Huichun Zhan

34 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huichun Zhan United States 15 411 279 239 80 68 40 682
Grazia Abou‐Ezzi United States 10 314 0.8× 101 0.4× 157 0.7× 59 0.7× 52 0.8× 13 614
Anke K. Bergmann Germany 12 244 0.6× 128 0.5× 113 0.5× 79 1.0× 18 0.3× 34 524
Norihiro Awaya Japan 12 203 0.5× 122 0.4× 204 0.9× 28 0.3× 41 0.6× 26 474
Monique Silvy France 13 134 0.3× 86 0.3× 207 0.9× 23 0.3× 165 2.4× 30 516
Vesna Spasovski Serbia 13 152 0.4× 131 0.5× 55 0.2× 152 1.9× 26 0.4× 41 452
Áine M. Prendergast Germany 8 218 0.5× 122 0.4× 295 1.2× 11 0.1× 42 0.6× 14 543
Qian-Fei Wang United States 13 327 0.8× 73 0.3× 233 1.0× 12 0.1× 92 1.4× 15 561
Omid F. Harandi United States 8 175 0.4× 317 1.1× 337 1.4× 24 0.3× 280 4.1× 8 703
Laura D. Healy United States 12 123 0.3× 95 0.3× 217 0.9× 19 0.2× 19 0.3× 15 442
Rongjia Zhu China 8 252 0.6× 119 0.4× 54 0.2× 13 0.2× 28 0.4× 12 478

Countries citing papers authored by Huichun Zhan

Since Specialization
Citations

This map shows the geographic impact of Huichun Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huichun Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huichun Zhan more than expected).

Fields of papers citing papers by Huichun Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huichun Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huichun Zhan. The network helps show where Huichun Zhan may publish in the future.

Co-authorship network of co-authors of Huichun Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Huichun Zhan. A scholar is included among the top collaborators of Huichun Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huichun Zhan. Huichun Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Haoyi & Huichun Zhan. (2025). Dexrazoxane makes doxorubicin-induced heart failure a rare event in sarcoma patients receiving high cumulative doses. Cardio-Oncology. 11(1). 29–29. 3 indexed citations
2.
Zheng, Haoyi, Syed Mahmood, Omar Khalique, & Huichun Zhan. (2024). Trastuzumab-Induced Cardiotoxicity: When and How Much Should We Worry?. JCO Oncology Practice. 20(8). 1055–1063. 6 indexed citations
3.
Lee, Sandy, et al.. (2024). Decoding Endothelial MPL and JAK2V617F Mutation: Insight Into Cardiovascular Dysfunction in Myeloproliferative Neoplasms. Arteriosclerosis Thrombosis and Vascular Biology. 44(9). 1960–1974. 4 indexed citations
4.
5.
6.
Lee, Sandy, et al.. (2022). JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm. Stem Cells. 40(4). 359–370. 5 indexed citations
7.
Kaushansky, Kenneth, et al.. (2021). Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm. Experimental Hematology. 100. 52–62. 3 indexed citations
8.
Jiang, Yaping, Sandy Lee, Juei‐Suei Chen, et al.. (2020). Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm. Journal of Thrombosis and Haemostasis. 18(12). 3359–3370. 27 indexed citations
9.
Kaushansky, Kenneth & Huichun Zhan. (2018). The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells. Advances in Biological Regulation. 69. 11–15. 18 indexed citations
10.
Lin, Chi Hua Sarah, Yu Zhang, Kenneth Kaushansky, & Huichun Zhan. (2018). JAK2V617F-bearing vascular niche enhances malignant hematopoietic regeneration following radiation injury. Haematologica. 103(7). 1160–1168. 19 indexed citations
11.
12.
Zhan, Huichun, et al.. (2017). The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms. Leukemia. 32(2). 462–469. 28 indexed citations
13.
Zhan, Huichun, et al.. (2016). JAK2V617F-Mutant Vascular Niche Promotes JAK2V617F Clonal Expansion in Myeloproliferative Neoplasms. Blood. 128(22). 952–952. 1 indexed citations
14.
Lin, Chi Hua Sarah, Kenneth Kaushansky, & Huichun Zhan. (2016). JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms. Blood Cells Molecules and Diseases. 62. 42–48. 25 indexed citations
15.
Zhan, Huichun, et al.. (2016). Clostridium difficile-associated clinical burden from lack of diagnostic testing in a Chinese tertiary hospital. Journal of Hospital Infection. 94(4). 386–388. 4 indexed citations
16.
Zhan, Huichun, Yupo Ma, Chi Hua Sarah Lin, & Kenneth Kaushansky. (2016). JAK2V617F-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation. Leukemia. 30(12). 2332–2341. 39 indexed citations
17.
Zhan, Huichun, et al.. (2015). Targeting glutamine metabolism in myeloproliferative neoplasms. Blood Cells Molecules and Diseases. 55(3). 241–247. 19 indexed citations
18.
Zhan, Huichun, Yupo Ma, & Kenneth Kaushansky. (2015). JAK2V617F-Mutant Megakaryocytes Contribute to Stem Cell Expansion in Myeloproliferative Neoplasms. Blood. 126(23). 485–485.
19.
Zhan, Huichun, Christopher Cardozo, Wayne Yu, et al.. (2012). MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients. Blood Cells Molecules and Diseases. 50(3). 190–195. 20 indexed citations
20.
Ye, Zhaohui, Huichun Zhan, Prashant Mali, et al.. (2009). Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 114(27). 5473–5480. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grazia Abou‐Ezzi Breakdown of academic impact, for papers by Anke K. Bergmann Breakdown of academic impact, for papers by Norihiro Awaya Breakdown of academic impact, for papers by Monique Silvy Breakdown of academic impact, for papers by Vesna Spasovski Breakdown of academic impact, for papers by Áine M. Prendergast Breakdown of academic impact, for papers by Qian-Fei Wang Breakdown of academic impact, for papers by Omid F. Harandi Breakdown of academic impact, for papers by Laura D. Healy Breakdown of academic impact, for papers by Rongjia Zhu
Rankless by CCL
2026